» Articles » PMID: 16144799

Early Block to Erythromegakaryocytic Development Conferred by Loss of Transcription Factor GATA-1

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2005 Sep 8
PMID 16144799
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Transcription factor GATA-1 is essential at multiple stages of hematopoiesis. Murine gene targeting and analysis of naturally occurring human mutations demonstrate that GATA-1 drives the maturation of committed erythroid precursors and megakaryocytes. Prior studies also suggest additional, poorly defined, roles for GATA-1 at earlier stages of erythromegakaryocytic differentiation. To investigate these functions further, we stimulated Gata1- murine embryonic stem-cell-derived hematopoietic cultures with thrombopoietin, a multistage cytokine. Initially, the cultures generated a wave of mutant megakaryocytes. However, these were rapidly overgrown by a unique population of thrombopoietin-dependent blasts that express immature markers and proliferate indefinitely. Importantly, on restoration of GATA-1 function, these cells differentiated into both erythroid and megakaryocytic lineages, suggesting that they represent bipotential progenitors. Identical cells are also present in vivo, as indicated by flow cytometry and culture analysis of fetal livers from Gata1- chimeric mice. Our findings indicate that loss of GATA-1 impairs the maturation of megakaryocyte-erythroid progenitors. This defines a new role for GATA-1 at a relatively early stage of hematopoiesis and provides potential insight into recent discoveries that human GATA1 mutations promote acute megakaryoblastic leukemia, a clonal malignancy with features of both erythroid and megakaryocyte maturation.

Citing Articles

Erythropoiesis: insights from a genomic perspective.

Cha H Exp Mol Med. 2024; 56(10):2099-2104.

PMID: 39349824 PMC: 11542026. DOI: 10.1038/s12276-024-01311-1.


Transcription factor networks disproportionately enrich for heritability of blood cell phenotypes.

Martin-Rufino J, Caulier A, Lee S, Castano N, King E, Joubran S bioRxiv. 2024; .

PMID: 39314298 PMC: 11419094. DOI: 10.1101/2024.09.09.611392.


GATA1 in Normal and Pathologic Megakaryopoiesis and Platelet Development.

Takasaki K, Chou S Adv Exp Med Biol. 2024; 1459:261-287.

PMID: 39017848 DOI: 10.1007/978-3-031-62731-6_12.


Chromatin loop dynamics during cellular differentiation are associated with changes to both anchor and internal regulatory features.

Bond M, Davis E, Quiroga I, Dey A, Kiran M, Love M Genome Res. 2023; 33(8):1258-1268.

PMID: 37699658 PMC: 10547260. DOI: 10.1101/gr.277397.122.


Transcription factors in megakaryocytes and platelets.

Yuan H, Liu Y, Zhang J, Dong J, Zhao Z Front Immunol. 2023; 14:1140501.

PMID: 36969155 PMC: 10034027. DOI: 10.3389/fimmu.2023.1140501.


References
1.
Kaushansky K . Thrombopoietin: accumulating evidence for an important biological effect on the hematopoietic stem cell. Ann N Y Acad Sci. 2003; 996:39-43. DOI: 10.1111/j.1749-6632.2003.tb03230.x. View

2.
Ferreira R, Ohneda K, Yamamoto M, Philipsen S . GATA1 function, a paradigm for transcription factors in hematopoiesis. Mol Cell Biol. 2005; 25(4):1215-27. PMC: 548021. DOI: 10.1128/MCB.25.4.1215-1227.2005. View

3.
Heyworth C, Pearson S, May G, Enver T . Transcription factor-mediated lineage switching reveals plasticity in primary committed progenitor cells. EMBO J. 2002; 21(14):3770-81. PMC: 126114. DOI: 10.1093/emboj/cdf368. View

4.
Gurbuxani S, Vyas P, Crispino J . Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome. Blood. 2003; 103(2):399-406. DOI: 10.1182/blood-2003-05-1556. View

5.
Wang X, Crispino J, Letting D, Nakazawa M, Poncz M, Blobel G . Control of megakaryocyte-specific gene expression by GATA-1 and FOG-1: role of Ets transcription factors. EMBO J. 2002; 21(19):5225-34. PMC: 129049. DOI: 10.1093/emboj/cdf527. View